Omicron Corona Variant : Cases of the new variant Omicron of coronavirus have now been reported in many countries, so the big question is whether the current vaccine will be effective on this new variant found in South Africa or not? What is the plan to stop the new wave? Know what Vaccine Makers say.
Several cases of Omicron variant have come to the fore
Omicron COVID-19 Variant: Tension has increased around the world regarding the Omicron variant, the World Health Organization has already warned about the new variant of corona, WHO called it ‘Variants of Concern’. Is. After this variant found in South Africa, a new round of sanctions has started once again in the whole world.
Vaccine makers made big claims
Restrictions ranging from travel restrictions to border seals are include in this. At the same time, the biggest question among all this is whether the current vaccine will work on the Omicron variant? This question is also because Omicron variant has been found in two people in Hong Kong, both of them had got the Pfizer vaccine. Let us tell you in detail what the vaccine makers are making about the Omicron variant.
Albert Bourla, CEO of American drug company Pfizer, said that Pfizer has started preparations for the Omicron variant. Talking to CNBC about this, he told that his company has started testing against the new variant. So that it can known whether it is effective against this variant or not. At the same time, Albert Bourla expressed the hope that Pfizer’s antiviral pill would also be effective against Omicron.
Moderna Vaccine said that they are preparing a booster shot for the new variant. In this regard, Paul Burton, the Chief Medical Officer of Moderna, told the BBC that – those who have got the vaccine, they are still safe. In such a situation, people who have not got the vaccine, are advised to get the Covid vaccine.
Johnson & Johnson Vaccine
Meanwhile, Johnson & Johnson has also started preparing a special vaccine for the Omicron variant.
Swedish and UK-based AstraZeneca said that it is looking into the effect of Omicron variant B.1.1. The company has expressed the hope that the drug in their vaccine will be effective against this variant. The company also said that they are currently testing a new variant of the AZD7442 antibody combination. Contains two powerful antibodies against the virus
The Russian Direct Investment Fund (RDIF) has shown the Sputnik vaccine made by the Gamleya Center to be effective against the Omicron variant. However, it has also been claimed that they are also making a booster dose for this new variant. RDIF also said that it has started making a new version of the Sputnik vaccine against the Omicron variant. Within 45 days, the Omicron version of the Sputnik vaccine will come to the public on a large scale. It has also been claimed that by 20 February 2022, 3 billion or 300 crore vaccine doses will be made.
Vaccine maker Novavax has also claimed that it is making a new vaccine in view of the new variant of Kovid 19. The vaccine will be made soon, after that it can be manufactured.
Inovio Pharmaceuticals Inc. has said that they have started testing their vaccine INO-4800 on a new variant. It will take about 2 weeks to complete the test. The company has hoped that the INO-4800 will work against the variants found in South Africa. This information was give by the company’s Senior Vice President Kate Broderick.